71230
硫柳汞钠
97.0-101.0% (on dried substance, T)
别名:
Mercury-([o-carboxyphenyl]thio)ethyl 钠盐, 乙基噻吩酸 钠盐, 乙汞硫柳酸钠, 乙汞硫水杨酸 钠盐
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
线性分子式:
2-(C2H5HgS)C6H4CO2Na
化学文摘社编号:
分子量:
404.81
UNSPSC Code:
51473202
NACRES:
NA.21
PubChem Substance ID:
EC Number:
200-210-4
Beilstein/REAXYS Number:
8169555
MDL number:
Assay:
97.0-101.0% (on dried substance, T)
Form:
powder
Quality Level
assay
97.0-101.0% (on dried substance, T)
form
powder
mp
234-237 °C (dec.) (lit.)
mode of action
enzyme | inhibits
SMILES string
[Na+].CC[Hg]Sc1ccccc1C([O-])=O
InChI
1S/C7H6O2S.C2H5.Hg.Na/c8-7(9)5-3-1-2-4-6(5)10;1-2;;/h1-4,10H,(H,8,9);1H2,2H3;;/q;;2*+1/p-2
InChI key
RTKIYNMVFMVABJ-UHFFFAOYSA-L
Biochem/physiol Actions
硫柳汞是一种巯基（硫醇）氧化剂，能抑制多种巯基依赖性酶和蛋白质，如PI3激酶依赖性蛋氨酸合成酶、谷氨酸转运受体和Na++K+依赖性ATP酶。
Analysis Note
溶解度（EP/BP）易溶于水，微溶或溶于乙醇（96%），几乎不溶于乙醚和二氯甲烷。
Other Notes
作为公司支持《关于汞的水俣公约》消除含汞化合物全球计划的一部分，自2021年1月起，将要求客户提供最终用途声明。硫柳汞钠的销售仅限于批准应用。
Disclaimer
对于美国客户：本品含汞。废弃后切勿放入垃圾桶，须按照地方、州或联邦法律处置。
Still not finding the right product?
Explore all of our products under 硫柳汞钠
signalword
Danger
Hazard Classifications
Acute Tox. 1 Dermal - Acute Tox. 2 Inhalation - Acute Tox. 2 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - STOT RE 2 Oral
target_organs
Kidney
存储类别
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
法规信息
危险化学品
非剧毒-急性毒性1
此项目有
Ildiko R Dunay et al.
Antimicrobial agents and chemotherapy, 48(12), 4848-4854 (2004-11-25)
Acute therapy with pyrimethamine plus sulfadiazine is the treatment of choice for reactivated toxoplasmic encephalitis (TE). Acute therapy is followed by lifelong maintenance therapy (secondary prophylaxis) with the same drugs at lower dosages. The use of pyrimethamine plus sulfadiazine is
John M Feller et al.
The Journal of clinical endocrinology and metabolism, 93(9), 3560-3567 (2008-06-12)
Hyperinsulinism with islet cell hyperplasia is a frequent complication, of unknown cause, in hemolytic disease of the newborn, occurring in Rh(D)-positive infants of Rh-isoimmunized Rh(D)-negative mothers, but not in infants with other hemolytic disorders. We investigated the possibility that trans-placentally
Pan-Chyr Yang et al.
Journal of the Formosan Medical Association = Taiwan yi zhi, 111(6), 333-339 (2012-07-04)
This study evaluated the immune response elicited by two formulations of an AS03(A)-adjuvanted H5N1 A/Indonesia/05/2005 prepandemic influenza vaccine, developed using manufacturing processes with or without thiomersal. In addition, it also evaluated compliance to the Centre for Biologics Evaluation and Research
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 71230-250G | 04061832404967 |
| 71230-10G | 04061835326174 |
| 71230-50G | 04061832404974 |